Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Eva-Maria Wicklein"'
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Despite trends towards the increased age of patients living with multiple sclerosis (MS), little is known about the response of older adults with MS to disease-modifying therapies (DMTs). Thus, a post-hoc analysis was undertaken u
Externí odkaz:
https://doaj.org/article/fedf9dea90eb4d2b8ebc6137cec10f20
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Background: The goal of the present cohort study was to review outcomes of patients exposed to interferon beta-1b during pregnancy. Methods: Pregnancy cases with exposure to interferon beta-1b reported to Bayer’s pharmacovigilance (PV) database fro
Externí odkaz:
https://doaj.org/article/1605d1889be243929c68ddb0ee341206
Autor:
Marianna Cortese, Xiaojing Peng, Kjetil Bjornevik, Clary B. Clish, Gilles Edan, Mark Freedman, Hans-Peter Hartung, Xavier Montalban, Rupert Sandbrink, Ernst-Wilhelm Radue, Frederik Barkhof, Eva-Maria Wicklein, Ludwig Kappos, Kassandra Munger, Alberto Ascherio
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b64dac2605313e6965e30ea60518175
https://doi.org/10.1212/wnl.0000000000204054
https://doi.org/10.1212/wnl.0000000000204054
Autor:
Sandy Yeo, Ann-Kathrin Frenz, Simone Heeg, Oisin Butler, Katsiaryna Holl, Eva-Maria Wicklein, Mark Rametta
Publikováno v:
Drugs-Real World Outcomes
Background Both interferon beta-1b (IFN-β-1b) and interferon beta-1a (IFN-β-1a) are immunomodulators that require regular subcutaneous self-administration by patients with multiple sclerosis (MS). However, no electronic autoinjector is available fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8f7bfb0bef87afbc7dd76b540b43f20
http://europepmc.org/articles/PMC8324614
http://europepmc.org/articles/PMC8324614
Autor:
Marianna, Cortese, Kassandra L, Munger, Elena H, Martínez-Lapiscina, Christian, Barro, Gilles, Edan, Mark S, Freedman, Hans-Peter, Hartung, Xavier, Montalbán, Frederick W, Foley, Iris Katharina, Penner, Bernhard, Hemmer, Edward J, Fox, Sven, Schippling, Eva-Maria, Wicklein, Ludwig, Kappos, Jens, Kuhle, Alberto, Ascherio, Henry F., McFarland
Publikováno v:
Neurology. 94:e1950-e1960
ObjectiveTo investigate whether vitamin D, smoking, and anti-Epstein-Barr virus (EBV) antibody concentrations predict long-term cognitive status and neuroaxonal injury in multiple sclerosis (MS).MethodsThis study was conducted among 278 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f775ca2dd1e690fe5cb9cd75cb8702
https://doi.org/10.1212/wnl.0000000000009371
https://doi.org/10.1212/wnl.0000000000009371
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Neurology
BMC Neurology
Background Despite trends towards the increased age of patients living with multiple sclerosis (MS), little is known about the response of older adults with MS to disease-modifying therapies (DMTs). Thus, a post-hoc analysis was undertaken using data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::878d325a505961ab0a5c966291cd4352
https://doi.org/10.1186/s12883-021-02347-w
https://doi.org/10.1186/s12883-021-02347-w
Autor:
Juan Manuel Escobar, Marianna Cortese, Gilles Edan, Mark S Freedman, Hans-Peter Hartung, Xavier Montalbán, Rupert Sandbrink, E-W Radü, Frederik Barkhof, Eva-Maria Wicklein, Ludwig Kappos, Alberto Ascherio, Kassandra L Munger
Publikováno v:
Multiple Sclerosis Journal. SAGE Publications Ltd
Manuel Escobar, J, Cortese, M, Edan, G, Freedman, M S, Hartung, H-P, Montalbán, X, Sandbrink, R, Radü, E W, Barkhof, F, Wicklein, E-M, Kappos, L, Ascherio, A & Munger, K L 2021, ' Body mass index as a predictor of MS activity and progression among participants in BENEFIT ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585211061861
Mult Scler
Manuel Escobar, J, Cortese, M, Edan, G, Freedman, M S, Hartung, H-P, Montalbán, X, Sandbrink, R, Radü, E W, Barkhof, F, Wicklein, E-M, Kappos, L, Ascherio, A & Munger, K L 2021, ' Body mass index as a predictor of MS activity and progression among participants in BENEFIT ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585211061861
Mult Scler
Background: There is a lack of studies on the association between obesity and conversion from a clinically isolated syndrome (CIS) to multiple sclerosis (MS). Objective: The aim of this study was to determine whether obesity predicts disease activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2944a9c03065581eadc4c0ca5a761fb8
https://research.vumc.nl/en/publications/cc7c10f1-efef-4760-94c9-2af089a93e7b
https://research.vumc.nl/en/publications/cc7c10f1-efef-4760-94c9-2af089a93e7b
Autor:
Katja Marja Hakkarainen, Rosa Juuti, Sarah Burkill, Yvonne Geissbühler, Meritxell Sabidó, Catrinel Popescu, Kiliana Suzart-Woischnik, Jan Hillert, Miia Artama, Auli Verkkoniemi-Ahola, Kjell-Morten Myhr, Juha Mehtälä, Shahram Bahmanyar, Scott Montgomery, Pasi Korhonen, Alessandra Adamo, Eva-Maria Wicklein, Metin Akbaba, Gustavo Borghesi, Evra Köfüncü, Nicholas Everage, Avni Pandhi, Maria Naylor, Anh Ly, Dominic Jack, Milorad Todorovic, Delphine Issard, Alexandra Macklin, Paola Primatesta, Richard Weitzman, Riho Klement, Minna Vehkala, Pia Vattulainen, Marta Korjagina, Hanna Gyllensten
Publikováno v:
Therapeutic Advances in Neurological Disorders
Therapeutic Advances in Neurological Disorders (TAND)
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Therapeutic Advances in Neurological Disorders (TAND)
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Background Our aim was to estimate and compare the prevalence of adverse pregnancy outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta (IFNB) and among women with MS unexposed to any MS disease-modifying drug (MSDMD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f51ad471aac8547aacb1701eaa956d9f
http://europepmc.org/articles/PMC7549181
http://europepmc.org/articles/PMC7549181
Autor:
Year Ltf Investigators, David Kb Li, Stuart D. Cook, Eva-Maria Wicklein, R. Koelbach, Dawn Langdon, Christoph Pohl, Douglas S. Goodin, Marcelo Kremenchutzky, Gary Cutter, Timothy O'Donnell, Anthony T. Reder, Anthony Traboulsee, Joel Oger
Publikováno v:
Multiple Sclerosis Journal. 25:837-847
Background: Long-term follow-up from the randomized trial of interferon beta-1b (IFNB-1b) permitted the assessment of different definitions of no evidence of disease activity (NEDA) for predicting long-term outcome in multiple sclerosis (MS). Objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4e58168284ed86cc1a82aefbb6ea92e
https://doi.org/10.1177/1352458518773511
https://doi.org/10.1177/1352458518773511
Autor:
Oisin Butler, Ann-Kathrin Frenz, Katsiaryna Holl, Mark Rametta, S. Werner, S. Yeo, Eva-Maria Wicklein
Publikováno v:
Value in Health. 23:S258-S259
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72f8dae004cdb5af82679a0b0a9c2853
https://doi.org/10.1016/j.jval.2020.04.898
https://doi.org/10.1016/j.jval.2020.04.898